Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-01-10
2006-01-10
Salimi, Ali R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100, C435S345000
Reexamination Certificate
active
06984492
ABSTRACT:
A method of treatment or prophylaxis of herpes infections and associated disease states by administration of compositions comprising immunoglobulins. Methods comprising intravenous and topical administration of immunoglobulins are provided.
REFERENCES:
patent: 5505945 (1996-04-01), Gristina et al.
patent: 5530102 (1996-06-01), Gristina et al.
patent: 5681565 (1997-10-01), Gristina et al.
patent: 5707627 (1998-01-01), Gristina et al.
patent: 5718899 (1998-02-01), Gristina et al.
patent: 5817312 (1998-10-01), Gristina et al.
patent: 2051 054 (1995-12-01), None
Rector et al , Infection and Immunity, Oct. 1982, vol. 38, No. 1, pp. 168-174.
Dix et al , Infection And Immunity, Oct. 1981, vol. 34, No. 1, pp. 192-199.
Boggess, K.A., et al.,“Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy,” Am. J. Obstet. Gynecol.,176(2): 443-451 (1997).
Corbino, N., et al.,“The role of anti-herpes specific serum IgA levels as a marker in cervical oncogenesis,” Eur. J. Gynaec. Oncol.,10(2): 103-108 (1989).
Habeeb, A.F.S.A., and R.D. Francis,“Preparation of human immunoglobulin free of plasmin and anticomplement activities,” Vox Sang.32(3): 143-158 (1977).
Leibl, H., et al.,Method for the isolation of biologically active monomeric immunoglobulin A from a plasma fraction, Journal of Chromatography B.,678(2):173-180 (1996).
European Patent Office Partial International Search Report (PCT/US2004/028559, dated Dec. 9, 2004).
Elrich, K.S., et al., “Prevention and Treatment of Experimental Herpes Simplex Virus Encephalitis with Human Immune Serum Globulin,”Antimicrobial Agents and Chemotherapy, 31(7): 1006-1009 (1987).
Epstein, S.P, et al., “Efficacy of Polyclonal Antibodies for Treatment of Ocular Herpes Simplex Infection,”Cornea, 20(5): 495-500 (2001).
LeBlanc, R.A., et al., “Treatment of HSV-1 Infection with Immunoglobulin or Acyclovir: Comparison of Their Effects on Viral Spread, Latency, and Reactivation,”Virology, 262(1): 230-236 (1999).
Raizman, M.B, and C.S. Foster, “Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice,”Current Eye Research, 7(8): 823-829 (1988).
Ritchie, M.H., et al., “Passive Transfer of Anti-Herpes Simplex Virus Type 2 Monoclonal and Polyclonal Antibodies Protect Against Herpes Simplex Virus Type 1-Induced but Not Herpes Simplex Virus Type 2-Induced Stromal Keratitis,”Investigative Opthalmology&Visual Science, 34(8): 2460-2468 (1993).
Betz Ulrich
Radtke Klaus-Peter
Salimi Ali R.
Talecris Biotherapeutics, Inc.
Womble Carlyle Sandridge & Rice PLLC
LandOfFree
Methods and compositions for treating herpes infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating herpes infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating herpes infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3552064